ASXL2-C2ORF44 Fusion FISH Probe
The ASXL2-C2ORF44 Fusion FISH Probe is used to confirm a fusion of the ASXL2 and C2ORF44 genes. The fusion of the ASXL2 and C2ORF44 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ASXL2-C2ORF44-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ASXL2-C2ORF44-20-AQAQ | 20 (40 μL) | 200 μL |
|
ASXL2 Gene Summary
This gene encodes a member of a family of epigenetic regulators that bind various histone-modifying enzymes and are involved in the assembly of transcription factors at specific genomic loci. Naturally occurring mutations in this gene are associated with cancer in several tissue types (breast, bladder, pancreas, ovary, prostate, and blood). This gene plays an important role in neurodevelopment, cardiac function, adipogenesis, and osteoclastogenesis. [provided by RefSeq, Feb 2017]
Gene Name: Additional Sex Combs Like 2, Transcriptional Regulator
Chromosome: CHR2: 25962252 -26101312
Locus: 2p23.3
Gene Diseases
The ASXL2 C2ORF44 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|